Provided by Tiger Trade Technology Pte. Ltd.

SCYNEXIS Inc

4.08
-0.1400-3.32%
Post-market: 4.090.0100+0.25%17:17 EDT
Volume:119.55K
Turnover:489.03K
Market Cap:40.52M
PE:-3.06
High:4.23
Open:4.19
Low:4.02
Close:4.22
52wk High:9.12
52wk Low:3.53
Shares:9.93M
Float Shares:7.51M
Volume Ratio:0.55
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3352
EPS(LYR):-1.3793
ROE:-18.38%
ROA:-20.82%
PB:0.61
PE(LYR):-2.96

Loading ...

Scynexis completes study of SCY-770

TIPRANKS
·
Oct 06

Scynexis Reports Phase 1 Data Show SCY-770 Well Tolerated in Healthy Adults for ADPKD Program

Reuters
·
Oct 06

Scynexis Announces Phase 1 Study Results for Scy-770, a Novel, Highly Selective, Oral Direct Ampk Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (Adpkd)

THOMSON REUTERS
·
Oct 06

Scynexis - Phase 2 Study of Scy-770 in Adpkd on Track to Initiate in Q4 2026

THOMSON REUTERS
·
Oct 06

Scynexis - Scy-770 Well Tolerated with Favorable Safety Profile at Higher Doses in Phase 1 Study

THOMSON REUTERS
·
Oct 06

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

GlobeNewswire
·
Oct 06

Brookline says BARDA contract a major positive for Scynexis’ SCY-247 program

TIPRANKS
·
Sep 29

Scynexis Wins BARDA Contract Worth up to $214 Million for SCY-247 Development

Reuters
·
Sep 28

Scynexis - Barda Contract Provides up to $214 Mln in Funding over 10 Years

THOMSON REUTERS
·
Sep 28

Scynexis Awarded Barda Contract Providing up to $214 Million in Non-Dilutive Funding for the Development of Scy-247

THOMSON REUTERS
·
Sep 28

Scynexis - Guidance for Scy-770 Milestones and Cash Runway into 2029 Unchanged

THOMSON REUTERS
·
Sep 28

Scynexis Files Form 3 Initial Beneficial Ownership Statement for Director Steven Keith Burke

Reuters
·
Sep 23

Scynexis appoints Burke to Board of Directors

TIPRANKS
·
Sep 22

Scynexis Names Akebia CMO Steven K. Burke to Board

Reuters
·
Sep 22

Scynexis Appoints Seasoned Industry Veteran Steven K. Burke, M.d., to Its Board of Directors

THOMSON REUTERS
·
Sep 22

Press Release: Scynexis Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to Its Board of Directors

Dow Jones
·
Sep 22

Scynexis Appoints Todd Minga, M.d., as Senior Vice President, Research & Development

THOMSON REUTERS
·
Sep 15

Press Release: Scynexis Appoints Todd Minga, M.D., as Senior Vice President, Research & Development

Dow Jones
·
Sep 15

Scynexis CFO Sanjay Subramanian Files Initial Beneficial Ownership Statement

Reuters
·
Sep 12

SCYNEXIS Names Sanjay Subramanian as CFO

MT Newswires Live
·
Sep 10